Curis, Inc. (CRIS)
0.8034
-0.03
(-3.29%)
USD |
NASDAQ |
Oct 02, 16:00
0.8495
+0.05
(+5.74%)
After-Hours: 20:00
Curis Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -243.4% |
| June 30, 2025 | -312.6% |
| March 31, 2025 | -446.1% |
| December 31, 2024 | -287.5% |
| September 30, 2024 | -344.3% |
| June 30, 2024 | -463.6% |
| March 31, 2024 | -569.3% |
| December 31, 2023 | -434.4% |
| September 30, 2023 | -430.0% |
| June 30, 2023 | -544.4% |
| March 31, 2023 | -503.2% |
| December 31, 2022 | -392.4% |
| September 30, 2022 | -470.6% |
| June 30, 2022 | -666.1% |
| March 31, 2022 | -783.1% |
| December 31, 2021 | -434.4% |
| September 30, 2021 | -363.6% |
| June 30, 2021 | -474.1% |
| March 31, 2021 | -453.5% |
| December 31, 2020 | -248.6% |
| September 30, 2020 | -217.9% |
| June 30, 2020 | -284.2% |
| March 31, 2020 | -358.4% |
| December 31, 2019 | -261.9% |
| September 30, 2019 | -225.4% |
| Date | Value |
|---|---|
| June 30, 2019 | -344.5% |
| March 31, 2019 | -559.4% |
| December 31, 2018 | -215.6% |
| September 30, 2018 | -253.7% |
| June 30, 2018 | -367.4% |
| March 31, 2018 | -435.5% |
| December 31, 2017 | -246.1% |
| September 30, 2017 | -632.4% |
| June 30, 2017 | -683.6% |
| March 31, 2017 | -738.7% |
| December 31, 2016 | -479.9% |
| September 30, 2016 | -1.61K% |
| June 30, 2016 | -672.0% |
| March 31, 2016 | -547.0% |
| December 31, 2015 | -643.3% |
| September 30, 2015 | -271.1% |
| June 30, 2015 | -390.3% |
| March 31, 2015 | -1.92K% |
| December 31, 2014 | -285.5% |
| September 30, 2014 | -316.2% |
| June 30, 2014 | -39.49% |
| March 31, 2014 | -433.1% |
| December 31, 2013 | -275.4% |
| September 30, 2013 | -25.93% |
| June 30, 2013 | -23.94% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Imunon, Inc. | -- |
| CEL-SCI Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -83.94% |
| Return on Invested Capital | -172.7% |
| Return on Net Operating Assets | -174.2% |